An Fc-silent OspA monoclonal antibody passively protects mice from tick and intradermal Borrelia burgdorferi challenge
PLOS One · 2026
DOI: 10.1371/journal.pone.0339749 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Daniel Palmer und 11 weiteren Autor:innen. Beteiligte Einrichtung: Wadsworth Center, New York Department of Health, Division of Infectious Disease, Albany, New York, United States of America. Hauptthemen laut MEDLINE: Borrelia burgdorferi, Antibodies, Monoclonal, Lyme Disease, Bacterial Outer Membrane Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
The monoclonal antibody, LA-2, has played a pivotal role in the development of Outer surface protein A (OspA)-based vaccines for Lyme disease, a multisystem illness caused by the tick-borne spirochete, Borrelia burgdorferi sensu lato. Of particular significance was the demonstration more than three decades ago that LA-2 equivalent antibody titers, defined by a competitive-inhibition ELISA, serve as a reliable correlate of vaccine-induced protection across different species, including humans. In vitro characterization of LA-2 has identified both complement-dependent and -independent activities, although which of these attributes contribute to protection against B. burgdorferi remains unresolved. To address this issue, we generated and characterized an “Fc-silent” version of LA-2 IgG1 carrying so-called LALAPG substitutions (L234A, L235A, P329G). We demonstrate that LA-2 LALAPG retained OspA binding activity but was severely attenuated in in vitro complement deposition and complement-dependent borreliacidal assays. Nonetheless, LA-2 LALAPG was as effective as LA-2 at passively protecting C3H mice against nymphal tick-mediated B. burgdorferi sensu stricto (s.s.) B31 challenge. LA-2 LALAPG was also equivalent to LA-2 in passively protecting BALB/c mice against intradermal B. burgdorferi s.s. B31 challenge. In the intradermal challenge model, viable spirochetes were not recoverable 24 h after injection from skin biopsies of mice treated with LA-2 or LA-2 LALAPG, and an influx of pro-inflammatory cytokines and chemokines to the injection site was abrogated. Collectively, these results suggest that LA-2’s primary mode of action involves direct physical interactions with the spirochete rather than complement-dependent killing. Elucidating these mechanisms may have implications for understanding the mechanistic correlates of OspA-based vaccine-induced immunity in humans.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Wadsworth Center, New York Department of Health, Division of Infectious Disease, Albany, New York, United States of America.
- Department of Biomedical Sciences, University of Albany, Albany, New York, United States of America.
- New York Structural Biology Center, New York, New York, United States of America.
- Deparrment of Microbiology, Tufts University, Boston, Massachusetts, United States of America.
ORCID-Profile: David J Vance, Nicholas J Mantis
Förderung
- NIH HHS
- National Institutes of Health
Zitieren
APA
Palmer, D., Shemshadian, A., Berman, K., Nobles, A., Willsey, G. G., Piazza, C. L., Freeman-Gallant, G., Rudolph, M. J., Bourgeois, J., Hu, L., Vance, D. J., & Mantis, N. J. (2026). An Fc-silent OspA monoclonal antibody passively protects mice from tick and intradermal Borrelia burgdorferi challenge. PLOS One. https://doi.org/10.1371/journal.pone.0339749
Vancouver
Palmer D, Shemshadian A, Berman K, Nobles A, Willsey GG, Piazza CL, et al. An Fc-silent OspA monoclonal antibody passively protects mice from tick and intradermal Borrelia burgdorferi challenge. PLOS One. 2026. doi:10.1371/journal.pone.0339749
BibTeX
@article{Palmer2026,
author = {Palmer, Daniel and Shemshadian, Atieh and Berman, Katherine and Nobles, Ariana and Willsey, Graham G and Piazza, Carol Lyn and Freeman-Gallant, Grace and Rudolph, Michael J and Bourgeois, Jeff and Hu, Linden and Vance, David J and Mantis, Nicholas J},
title = {An Fc-silent OspA monoclonal antibody passively protects mice from tick and intradermal Borrelia burgdorferi challenge},
journal = {PLOS One},
year = {2026},
doi = {10.1371/journal.pone.0339749}
}
EUVIMED